Khan Bilal Arshad — SEC Form 4 filings
SEC reporting owner CIK 2108044. 2 Form 4 filings on record with FilingPulse; latest filed 2026-02-11.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2026-02-09 to 2026-02-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 135,000 shares, $2,160,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 115,000 shares @ $16.00 ($1,840,000) in SpyGlass Pharma, Inc., filed 2026-02-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | Director | 2 | 2 legs · 135,000 sh · $2,160,000 | — | 1 |
Form 4 filings — Khan Bilal Arshad
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-11 | 4 | SpyGlass Pharma, Inc. (SGP) | Purchase (P): 20,000 @ $16 · Purchase (P): 115,000 @ $16 | EDGAR |
| 2026-02-09 | 4 | SpyGlass Pharma, Inc. (SGP) | Grant/award (A): 13,700 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2108044 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →